David A. Siegel Biocryst Pharmaceuticals Inc Transaction History

Two Sigma Advisers, LP

  • $47 Billion
  • Q3 2025

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Two Sigma Advisers, LP holds 4,240,712 shares of BCRX stock, worth $30 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
4,240,712
Previous 4,228,412 0.29%
Holding current value
$30 Million
Previous $37.9 Million 15.04%
% of portfolio
0.07%
Previous 0.08%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$7.55 - $9.06 $92,865 - $111,438
12,300 Added 0.29%
4,240,712 $32.2 Million
Q2 2025

Aug 14, 2025
BUY
$6.41 - $11.19 $6.46 Million - $11.3 Million
1,007,700 Added 31.29%
4,228,412 $37.9 Million
Q1 2025

May 15, 2025
BUY
$7.06 - $9.39 $5.09 Million - $6.77 Million
720,900 Added 28.84%
3,220,712 $24.2 Million
Q4 2024

Feb 14, 2025
BUY
$7.03 - $8.43 $2.24 Million - $2.69 Million
318,800 Added 14.62%
2,499,812 $18.8 Million
Q3 2024

Nov 14, 2024
BUY
$6.41 - $8.69 $1.68 Million - $2.27 Million
261,500 Added 13.62%
2,181,012 $16.6 Million
Q2 2024

Aug 14, 2024
SELL
$4.13 - $6.79 $2.29 Million - $3.76 Million
-553,900 Reduced 22.39%
1,919,512 $11.9 Million
Q1 2024

May 15, 2024
BUY
$4.89 - $7.65 $1 Million - $1.57 Million
205,400 Added 9.06%
2,473,412 $12.6 Million
Q4 2023

Feb 14, 2024
SELL
$4.98 - $6.77 $502,482 - $683,093
-100,900 Reduced 4.26%
2,268,012 $13.6 Million
Q3 2023

Nov 14, 2023
BUY
$6.71 - $7.92 $1.55 Million - $1.83 Million
231,300 Added 10.82%
2,368,912 $16.8 Million
Q2 2023

Aug 14, 2023
SELL
$6.96 - $8.81 $453,096 - $573,531
-65,100 Reduced 2.96%
2,137,612 $15 Million
Q1 2023

May 15, 2023
BUY
$7.94 - $11.84 $1.84 Million - $2.74 Million
231,800 Added 11.76%
2,202,712 $18.4 Million
Q4 2022

Feb 14, 2023
SELL
$10.5 - $14.2 $471,450 - $637,580
-44,900 Reduced 2.23%
1,970,912 $22.6 Million
Q3 2022

Nov 14, 2022
SELL
$10.79 - $14.81 $729,404 - $1 Million
-67,600 Reduced 3.24%
2,015,812 $25.4 Million
Q2 2022

Aug 15, 2022
BUY
$7.89 - $17.88 $2.46 Million - $5.59 Million
312,400 Added 17.64%
2,083,412 $22 Million
Q1 2022

May 16, 2022
SELL
$11.56 - $19.76 $4.4 Million - $7.53 Million
-380,900 Reduced 17.7%
1,771,012 $28.8 Million
Q4 2021

Feb 14, 2022
BUY
$11.18 - $15.46 $2.58 Million - $3.57 Million
230,900 Added 12.02%
2,151,912 $29.8 Million
Q3 2021

Nov 15, 2021
BUY
$14.21 - $17.65 $17.2 Million - $21.4 Million
1,212,900 Added 171.29%
1,921,012 $27.6 Million
Q2 2021

Aug 16, 2021
BUY
$9.5 - $17.24 $4.6 Million - $8.34 Million
483,900 Added 215.82%
708,112 $11.2 Million
Q1 2021

May 17, 2021
SELL
$7.37 - $13.61 $8 Million - $14.8 Million
-1,085,500 Reduced 82.88%
224,212 $2.28 Million
Q4 2020

Feb 16, 2021
SELL
$3.37 - $8.61 $1.95 Million - $4.99 Million
-579,600 Reduced 30.68%
1,309,712 $9.76 Million
Q3 2020

Nov 16, 2020
SELL
$3.43 - $5.53 $787,185 - $1.27 Million
-229,500 Reduced 10.83%
1,889,312 $6.49 Million
Q2 2020

Aug 14, 2020
BUY
$1.9 - $5.61 $985,910 - $2.91 Million
518,900 Added 32.43%
2,118,812 $10.1 Million
Q1 2020

May 15, 2020
BUY
$1.6 - $4.11 $156,960 - $403,191
98,100 Added 6.53%
1,599,912 $3.2 Million
Q4 2019

Feb 14, 2020
BUY
$1.59 - $3.45 $996,771 - $2.16 Million
626,900 Added 71.65%
1,501,812 $5.18 Million
Q3 2019

Nov 14, 2019
BUY
$2.5 - $3.73 $1.09 Million - $1.62 Million
435,300 Added 99.02%
874,912 $2.51 Million
Q2 2019

Aug 14, 2019
BUY
$2.91 - $9.15 $715,278 - $2.25 Million
245,800 Added 126.82%
439,612 $1.67 Million
Q1 2019

May 15, 2019
BUY
$7.38 - $9.72 $209,592 - $276,048
28,400 Added 17.17%
193,812 $1.58 Million
Q4 2018

Feb 14, 2019
SELL
$6.51 - $9.6 $213,528 - $314,880
-32,800 Reduced 16.55%
165,412 $1.34 Million
Q3 2018

Nov 14, 2018
BUY
$5.52 - $7.99 $160,080 - $231,710
29,000 Added 17.14%
198,212 $1.51 Million
Q2 2018

Aug 14, 2018
BUY
$4.6 - $6.52 $346,895 - $491,686
75,412 Added 80.4%
169,212 $970,000
Q1 2018

May 15, 2018
SELL
$4.35 - $5.82 $2,610 - $3,492
-600 Reduced 0.64%
93,800 $447,000
Q4 2017

Feb 14, 2018
BUY
$4.16 - $5.33 $37,024 - $47,437
8,900 Added 10.41%
94,400 $464,000
Q3 2017

Nov 14, 2017
BUY
$4.1 - $5.97 $350,549 - $510,435
85,500
85,500 $448,000

Others Institutions Holding BCRX

# of Institutions
310
Shares Held
200M
Call Options Held
640K
Put Options Held
507K
View Full List

About BIOCRYST PHARMACEUTICALS INC

BCRX Quotes by TradingView
  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.32B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email